Catalyst
Slingshot members are tracking this event:
Gelesis (PTCHF) Announces Safety Data from First-In-Human Study Evaluating Gelesis200 in Weight Loss and Improved Glycemic Control in Patients with Type 2 Diabetes
- Source Link:
- http://www.gelesis.com/press-releases/05032016.php
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 03, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Safety Data, First-in-human Study, Gelesis200, Weight Loss, Improved Glycemic Control, Type 2 Diabetes
